tachycardia tirzepatide increased force of contraction in the isolated human atrium | Naunyn-Schmiedeberg's Archives of Pharmacology REFERENCES: 📚American Heart Association (2020)

This reflects the uncertainty

It is not medical advice, and nothing in it is a prescription or a personal recommendation

Consumers should be wary of dietary supplements claiming to contain GLP-1 or promising "GLP-1-like" effects, as these claims are not FDA-approved and lack scientific validity

This is an important consideration for patients with established cardiovascular disease

Earlier framings of "0.34 partial agonist at GCGR" or "0.4 softened agonist at GLP-1R" mistook potency ratios (EC50_LY EC50_native) for efficacy multipliers (E_max_LY E_max_native) and are retracted

So, while the internet debates the mythical origins of these amazing molecules, the real work continues in labs around the world